AMLOVAN HCT 5/160/25 mg Tablet/ Film coated

What is AMLOVAN HCT 5/160/25 mg

AMLOVAN HCT 5/160/25 mg is a film-coated tablet that contains a combination of Amlodipine, Valsartan, and Hydrochlorothiazide. This medication is used to treat high blood pressure. Amlodipine is a calcium channel blocker that helps to dilate blood vessels, thus reducing blood pressure. Valsartan, an ARB, lowers blood pressure by blocking the action of angiotensin II, a substance that causes blood vessels to constrict. Hydrochlorothiazide is a diuretic that helps the body eliminate excess fluid, further contributing to lower blood pressure. The combination of these three drugs provides a comprehensive approach to managing hypertension.

How to use AMLOVAN HCT 5/160/25 mg

AMLOVAN HCT 5/160/25 mg tablets are administered orally. They can be taken with or without food. Follow the dosage instructions provided by your healthcare provider. Swallow the tablet whole with a glass of water. Avoid chewing or crushing the tablet to maintain the integrity of the film coating and the controlled release of the medication. Consistent daily use is crucial for effective blood pressure management.

Mode of Action AMLOVAN HCT 5/160/25 mg

AMLOVAN HCT 5/160/25 mg is a film-coated tablet designed for controlled release. The film coating helps to release the medication gradually, providing sustained therapeutic effects. The tablet should be swallowed whole with a glass of water and must not be chewed or crushed. This mode of administration ensures effective treatment of high blood pressure.

AMLOVAN HCT 5/160/25 mg Interactions AMLOVAN HCT 5/160/25 mg

AMLOVAN HCT 5/160/25 mg can interact with several types of medications. The combination of Amlodipine, Valsartan, and Hydrochlorothiazide may enhance the effects of other antihypertensives, potentially leading to hypotension. Additionally, the use of NSAIDs can interfere with the effectiveness of Valsartan. Monitoring of electrolyte levels is also important as Hydrochlorothiazide can affect potassium and sodium levels. Always disclose all other medications and supplements to your healthcare provider to manage interaction risks.

Dosage of AMLOVAN HCT 5/160/25 mg

The recommended dose for AMLOVAN HCT 5/160/25 mg is one tablet taken once daily. The dosage may be adjusted based on the patient’s blood pressure and response to treatment. Follow your healthcare provider’s instructions for dosage and do not exceed the recommended amount. Regular blood pressure monitoring is important for dose adjustments.

Possible side effects of AMLOVAN HCT 5/160/25 mg

Side effects associated with AMLOVAN HCT 5/160/25 mg may include dizziness, headache, fatigue, and hypotension. Hydrochlorothiazide can affect electrolyte levels, leading to issues such as hypokalemia or hyponatremia. Swelling in the extremities may also occur. If side effects become severe or persistent, seek medical advice. Monitoring of electrolytes is advised.

AMLOVAN HCT 5/160/25 mg Contraindications AMLOVAN HCT 5/160/25 mg

Information not available.

Storage of AMLOVAN HCT 5/160/25 mg

AMLOVAN HCT 5/160/25 mg should be stored at room temperature, protected from moisture and heat. Keep the tablets in their original packaging with the container tightly closed. Ensure that the medication is out of reach of children. Dispose of any unused or expired medication according to local disposal regulations.